Press releases

Search engine

Year:

BCN Health Booster accelerator companies close the programme with 107.5 million euros in new funding

GENESIS Biomed es consolida com un actor clau per al creixement i dinamització de l’ecosistema nacional d’innovació en salut

GENESIS Biomed consolidates its position as a key player in the growth and revitalisation of the Spanish health innovation ecosystem

Eugin lidera un projecte de 3,5 milions d’euros per a millorar la implantació embrionària, associada a més del 30% dels embarassos fallits

Eugin Group leads €3.5-million project to improve embryo implantation, a factor associated with over 30% of failed pregnancies

The public ecosystem of the Barcelona Science Park raises 70 million euros in 2023, 40% more than in 2022

Fecundis secures $2.4 million in a seed funding round

The two research centres with ties to Hospital Clínic join the Parc Científic de Barcelona

The “STEAM Talks” programme uses humour to spread science among secondary school students

Barcelona Science Park companies receive €85.4 million in investment in 2023, 40% of the total in the BioRegion of Catalonia

Hemostatics, CUN and ICIQ receive €2.5 M to validate a revolutionary therapy against disabling and lethal haemorrhage

Bioingenium invests €1.5m in a new production plant

The companies of the BCN Health Booster accelerator raise €51.8 M in the first year of the programme

MeteoSim wins World Bank competition to implement a numerical weather forecasting model in Malawi

IDP Pharma starts clinical trials of its first-in-class IDP-121 drug in hematological cancers and opens a financing round of €1M for the first phase of the study

Barcelona Science Park companies break record after raising €142M in 2022

First baby born as a result of a new reproduction technique that activates sperm

MiMARK Diagnostics equipment. From left to right: Cristina Vilarmau, Eva Colàs, Javier Carvajal, Marina Rigau, Eva Coll and Antonio Gil. Photographer: Miquel Coll.)

MiMARK Diagnostics raises €1M to accelerate the development of its in vitro diagnostic assay for endometrial cancer

La 19ª edición de la Feria Investigación en Directo lleva a debate los límites éticos de la ciencia

The 19th edition of the Live Research Fair holds the debate on the ethical limits of science

The world’s first clinical trial of Maternal Spindle Transfer technique shows its efficacy to treat infertility

Barcelona Science Park refinances the €36.7 M debt with the Ministry of Science and Innovation

GENESIS Biomed continues growing and adding value in biomedical sector

PCB

Barcelona Science Park, a strategic hub for public R&D&I of excellence

Schülke & Mayr GmbH acquires Spanish company Vesismin Health

Hallmark Barcelona Science Park innovation

Vesismin crea un programa pioner per a l'abordatge  integral de les infeccions hospitalàries

Vesismin creates pioneering programme with comprehensive approach to hospital infections

La nord-americana VeriSIM Life adquireix la startup Molomics Biotech

US company VeriSIM Life acquires start-up Molomics Biotech

Un viatge fascinant per la recerca

A fascinating journey through research

Spanish start-up Real Deal Milk is developing a system to produce cow’s milk without the animal’s intervention

Barcelona Science Park sees all-time record in new companies and occupancy

Dr Carlos Sebastian

Connection shown between glucose metabolism and colorectal tumorigenesis

Baula begins wide distribution of sustainable-format cleaning products

ISCIII and IDP Pharma researchers validate efficacy of a new molecule to treat glioblastoma

Winners of second “ReimagineScience” initiative to bring clinical research to young people receive their awards at Barcelona Science Park

BCN Health Booster accelerator kicks off with eleven business projects in health innovation

Farmaprojects opens a GMP laboratory for quality control and release of medicines in the Barcelona Science Park

Oncoheroes out-licences volasertib to US Notable Labs for adult cancers

The German specialty chemicals company Evonik acquires Spanish biotech firm Infinitec Activos

Moirai Biodesign creates an innovative synthetic RNA design software that will propel the development of state-of-the-art therapies, diagnostic methods and vaccines

Dan*na launches a pilot plant of bioplastic production for biomedical and technological sector in the Barcelona Science Park

BCN Health Booster accelerator is launched

Chemotargets announces first AI-Designed drug for Huntington’s disease to enter clinical trials

A sperm whale in the Park

Vesismin Health has consolidated its leadership in the market as a provider of hospital infection control solutions

Qiagen doubles its R&D facilities in the Barcelona Science Park to increase action capacity against COVID-19

The Barcelona Science Park is committed to becoming Catalonia’s Medtech company hub

Oncoheroes Biosciences receives from FDA the Rare Pediatric Disease Designation (RPDD) to volasertib for rhabdomyosarcoma

Promoting scientific careers in times of COVID-19

First foal born in Spain using a procedure which enhances reproductive efficiency and genetic preservation in elite animals

Alliance between the Hospital del Mar Medical Research Institute and Chemotargets to accelerate the design of new cancer therapies

Droplite opens seed round of 600.000€ to accelerate the manufacturing development of its smart medical diagnostics device

SOM Biotech announces the in vitro confirmation of three drug candidates for COVID-19 in collaboration with the Ewha Womans University

Nostrum Biodiscovery appoints Ezequiel Mas as its new CEO and embarks on an ambitious expansion plan

The PCB’s scientific community joins the fight against SARS-CoV-2

The green cleaning company Baula takes the leap to the B2C market

Cebiotex kicks off a €4 million Series A round to speed up clinical trials for its first oncology treatment

Barcelona Science Park opens 19 new laboratories to promote the health industry

Meteosim and Olfasense join forces against environmental pollution due to odours

Molomics opens an investment round to accelerate an innovative project against Parkinson’s

GalChimia doubles the surface of its R&D&I center at the Barcelona Science Park

SOM Biotech closes a financing round of 7M Euros

Aromics recieves 1 M€ from the European Union to boost its drug against the asbestos-related hallmark cancer

Kelly vs Kelly

Iproteos, IBEC and VHIR to develop an innovative therapy against solid tumors sòlids

Barcelona Science Park celebrates 20 years as a scientific and business innovation centre

Launching MedTeX, the accelerator for medical technology

DTI Foundation celebrates its 10th anniversary at Barcelona Science Park

GalChimia opens an R&D centre in the Barcelona Science Park

Kelly Arrontes blends art and science in her “Water is Life” mural

From African clawed frog oocytes… to drugs that are activated by light

€4 million in search of innovative health ideas

Bioinformatics company Mind the Byte acquires Intelligent Pharma